REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Innovita Research (Lithuania)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Business Support Services
Secondary Activities: General Medical and Surgical Hospitals
Full name: UAB Innovita Research Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Innovita Research is an enterprise in Lithuania, with the main office in Vilnius. The company operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) sector. It was established on August 29, 2005. 30 (2025) employees currently work for UAB Innovita Research. The company’s latest financial report indicates a net sales revenue increase of 53.84% in 2024. The enterprise’s net profit margin decreased by 14.47% in 2024.

Headquarters
Laisves pr. 125A
Vilnius; Vilnius county; Postal Code: LT-06118

Contact Details: Purchase the UAB Innovita Research report to view the information.

Basic Information
Total Employees:
Purchase the UAB Innovita Research report to view the information.
Registered Capital:
Purchase the UAB Innovita Research report to view the information.
Financial Auditors:
Purchase the UAB Innovita Research report to view the information.
Incorporation Date:
August 29, 2005
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after UAB Innovita Research report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
53.84%
Total operating revenue
53.84%
Net Profit (Loss) for the Period
-78.54%
Total equity
9.21%
Net Profit Margin
-14.47%
Return on Equity (ROE)
-34.49%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?